ACAD
Acadia Pharmaceuticals Inc.
stockNASDAQ
Market OpenNov 10, 2026 1:57:36 PM EST
18.08USD+9.576%(+1.58)3,880,528
Pre-marketNov 10, 2026 9:19:30 AM EST
16.50USD0.000%(0.00)
ACAD Financials
In Q3 FY 2026 (ended ), Acadia Pharmaceuticals Inc. (ACAD) reported revenue of $342.29M, net income of $53.52M, operating cash flow of $11.5M, and assets of $1.79B (filed ).
Loading financial statements…